232 related articles for article (PubMed ID: 21593192)
1. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
Silva A; Laranjeira AB; Martins LR; Cardoso BA; Demengeot J; Yunes JA; Seddon B; Barata JT
Cancer Res; 2011 Jul; 71(14):4780-9. PubMed ID: 21593192
[TBL] [Abstract][Full Text] [Related]
2. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).
Barata JT; Cardoso AA; Nadler LM; Boussiotis VA
Blood; 2001 Sep; 98(5):1524-31. PubMed ID: 11520803
[TBL] [Abstract][Full Text] [Related]
4. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
[TBL] [Abstract][Full Text] [Related]
5. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression.
Wang F; Li Z; Zhou J; Wang G; Zhang W; Xu J; Liang A
J Exp Clin Cancer Res; 2021 Aug; 40(1):259. PubMed ID: 34407842
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Zenatti PP; Ribeiro D; Li W; Zuurbier L; Silva MC; Paganin M; Tritapoe J; Hixon JA; Silveira AB; Cardoso BA; Sarmento LM; Correia N; Toribio ML; Kobarg J; Horstmann M; Pieters R; Brandalise SR; Ferrando AA; Meijerink JP; Durum SK; Yunes JA; Barata JT
Nat Genet; 2011 Sep; 43(10):932-9. PubMed ID: 21892159
[TBL] [Abstract][Full Text] [Related]
8. IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.
Barata JT; Boussiotis VA; Yunes JA; Ferrando AA; Moreau LA; Veiga JP; Sallan SE; Look AT; Nadler LM; Cardoso AA
Blood; 2004 Mar; 103(5):1891-900. PubMed ID: 14615384
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
[TBL] [Abstract][Full Text] [Related]
10. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
González-García S; García-Peydró M; Alcain J; Toribio ML
Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
[TBL] [Abstract][Full Text] [Related]
11. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
[TBL] [Abstract][Full Text] [Related]
12. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2013 May; 53(2):211-22. PubMed ID: 23234870
[TBL] [Abstract][Full Text] [Related]
13. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
14. Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.
Melão A; Spit M; Cardoso BA; Barata JT
Haematologica; 2016 Nov; 101(11):1368-1379. PubMed ID: 27470599
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL.
Rodriguez S; Abundis C; Boccalatte F; Mehrotra P; Chiang MY; Yui MA; Wang L; Zhang H; Zollman A; Bonfim-Silva R; Kloetgen A; Palmer J; Sandusky G; Wunderlich M; Kaplan MH; Mulloy JC; Marcucci G; Aifantis I; Cardoso AA; Carlesso N
Leukemia; 2020 May; 34(5):1241-1252. PubMed ID: 31772299
[TBL] [Abstract][Full Text] [Related]
16. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.
Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA
Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936
[TBL] [Abstract][Full Text] [Related]
17. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
[TBL] [Abstract][Full Text] [Related]
18. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract][Full Text] [Related]
19. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.
Sanda T; Tyner JW; Gutierrez A; Ngo VN; Glover J; Chang BH; Yost A; Ma W; Fleischman AG; Zhou W; Yang Y; Kleppe M; Ahn Y; Tatarek J; Kelliher MA; Neuberg DS; Levine RL; Moriggl R; Müller M; Gray NS; Jamieson CH; Weng AP; Staudt LM; Druker BJ; Look AT
Cancer Discov; 2013 May; 3(5):564-77. PubMed ID: 23471820
[TBL] [Abstract][Full Text] [Related]
20. T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
Buffière A; Uzan B; Aucagne R; Hermetet F; Mas M; Nassurdine S; Aznague A; Carmignac V; Tournier B; Bouchot O; Ballerini P; Barata JT; Bastie JN; Delva L; Pflumio F; Quéré R
Oncogene; 2019 Nov; 38(48):7357-7365. PubMed ID: 31417180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]